Using a genetic model of breast cancer in GRP78–deficient mice, GRP78 heterozygous mice have no effect on organ development or antibody production but show significant inhibition of in situ-generated tumor growth and tumor angiogenesis [47]. The gene discussed is HSPA5; the disease is breast cancer.